Atovaquone
- Product NDC
- 0121-0888
- 11-digit product format
- 001210888
- Labeler code
- 0121
- Product ID
- 0121-0888_ed380892-72da-aee8-e053-2995a90a8d1f
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Atovaquone
- Dosage form
- SUSPENSION
- Route
- ORAL
- Labeler
- Pharmaceutical Associates, Inc.
- Application
- ANDA209105
- Marketing category
- ANDA
- Marketing start
- 2018-11-07
- Marketing end
- 0000-00-00
- Substance
- ATOVAQUONE
- Active strength
- 750 mg/5mL
- Pharmacologic classes
- Antimalarial [EPC], Antiprotozoal [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0121-0888-18 | 00121088818 | 3 TRAY in 1 CASE (0121-0888-18) > 6 CUP, UNIT-DOSE in 1 TRAY > 5 mL in 1 CUP, UNIT-DOSE (0121-0888-05) | 3 tray | 2020-04-30 | 0000-00-00 | No | No | Current |
| 0121-0888-42 | 00121088842 | 7 TRAY in 1 CASE (0121-0888-42) > 10 CUP, UNIT-DOSE in 1 TRAY > 5 mL in 1 CUP, UNIT-DOSE (0121-0888-05) | 7 tray | 2020-04-30 | 0000-00-00 | No | No | Current |